plant derived beta-galactosidase-lectin fusion protein (Biostrategies)

N/A

Report date: 2025/03/20 09:28:30

Base Information

Drug Nameplant derived beta-galactosidase-lectin fusion protein (Biostrategies)
Drug Alias Nameenzyme replacement therapy (BioStrategies)
ClassificationBiologics > Protein drugs > EnzymeBiologics > Protein drugs > Recombinant protein > Fusion proteinNatural product/Extract
Mechanisms of ActionBeta-galactosidase modulators
TargetsBeta-galactosidase
Therapy Area/IndicationsGangliosidosis, GM1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioStrategies LC
China Registration ClassN/A

Develop Information

Active CompaniesBioStrategies LC
Inactive CompaniesN/A
Active IndicationsGangliosidosis, GM1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A